(Q44760560)

6 December 2017

Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors (English)

1 reference

6 December 2017

Dirk Brehmer

1

1 reference

6 December 2017

Klaus Godl

2

1 reference

6 December 2017

Birgit Zech

3

1 reference

6 December 2017

Josef Wissing

4

1 reference

6 December 2017

Henrik Daub

5

1 reference

6 December 2017

9 February 2004

1 reference

Molecular & Cellular Proteomics

6 December 2017

1 reference

6 December 2017

3

1 reference

6 December 2017

490-500

1 reference

6 December 2017

5

1 reference

Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions

6 December 2017

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Kinases as therapeutic targets for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Specificity and mechanism of action of some commonly used protein kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Inhibitor affinity chromatography: profiling the specific reactivity of the proteome with immobilized molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Synthetic small molecules that control stem cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Rediscovering the sweet spot in drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

An efficient proteomics method to identify the cellular targets of protein kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Cloning of human adenosine kinase cDNA: sequence similarity to microbial ribokinases and fructokinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Molecular cloning and characterization of a novel human STE20-like kinase, hSLK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

CB 1954: From the Walker Tumor to NQO2 and VDEPT

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Design, synthesis, and structure-activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Induction of apoptosis by SLK, a Ste20-related kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Caspase 3 cleavage of the Ste20-related kinase SLK releases and activates an apoptosis-inducing kinase domain and an actin-disassembling region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Issues and progress with protein kinase inhibitors for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Beyond Herceptin and Gleevec

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

A method for the comprehensive proteomic analysis of membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

Inhibition of voltage-dependent sodium channels by Ro 31-8220, a 'specific' protein kinase C inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M300139-MCP200

10.1074/MCP.M300139-MCP200

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference